Bingham, Catherine Elizabeth, Dame
At least 9 active companies
These details are public data from the Companies House register.
- Nationality
- British
- Country of residence
- United Kingdom
Appointments 9 current
Not a complete list. See all appointments on Companies House
Director · Appointed 31 October 2013
Active
Net assets £37.3M, 2021 accounts (newer filed) · Incorporated 2007
Director · Appointed 1 February 2017
Active
Group accounts · Incorporated 2016
Director · Appointed 19 August 2011
Active
Group accounts · Incorporated 2011
Director · Appointed 20 September 2004
Active
Group accounts · Incorporated 2004
LLP Designated Member · Appointed 2 August 2004
Active
Full accounts · Incorporated 2004 · None Supplied
Former appointments (11)
Director · Appointed 9 July 2021 · Resigned 11 July 2024
Company active
Director · Appointed 4 December 2017 · Resigned 28 June 2021
Company active
Director · Appointed 4 December 2017 · Resigned 17 June 2021
Company active
Director · Appointed 11 November 2015 · Resigned 27 June 2016
Company active
Director · Appointed 4 September 2013 · Resigned 10 November 2015
Company active
Director · Appointed 26 October 2011 · Resigned 11 February 2015
Company active
Director · Appointed 4 October 2010 · Resigned 10 February 2014
Company active
Director · Appointed 7 December 2009 · Resigned 17 June 2021
Company active
Director · Appointed 7 February 2009 · Resigned 23 June 2014
Company active
Director · Appointed 31 August 2007 · Resigned 28 May 2010
Company active
Director · Appointed 1 January 2002 · Resigned 31 December 2011
Company active
Works with
Officers serving alongside Bingham, Catherine Elizabeth, Dame
Al-Hallaq, Rana
Director at Autifony Therapeutics Limited
Director at Enara Bio Limited
Director at Sitryx Therapeutics Limited
Ang, Robert Yuen Lee, Dr
Director at Enara Bio Limited
Anninga, Bauke, Dr
Director at Enara Bio Limited
Astley-Sparke, Philip Christopher
Director at Mestag Therapeutics Ltd
Aziz, Kabeer
Director at Pulmocide Limited
LLP Member at SV Health Managers LLP